The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation
Open accessAbstract
Inflammatory activation of microglia in response to neurodegenerative changes in diseases such as Alzheimer's disease (AD) and Parkinson's disease has been extensively described. These observations have suggested that inflammation could be contributing to disease progression. In this paper, the potential role of CD200 and CD200 receptor (CD200R), whose known functions are to activate anti-inflammatory pathways and induce immune tolerance through binding of CD200 to CD200 receptor (CD200R), was studied in AD. Quantitative studies showed a significant decrease in CD200 protein and mRNA in AD hippocampus and inferior temporal gyrus, but not cerebellum. Immunohistochemistry of brain tissue sections of hippocampus, superior frontal gyrus, inferior temporal gyrus and cerebellum from AD and non-demented cases demonstrated a predominant, though heterogeneous, neuronal localization for CD200. Decreased neuronal expression was apparent in brain regions affected by AD pathology. There was also a significant decrease in CD200R mRNA expression in AD hippocampus and inferior temporal gyrus, but not cerebellum. Low expression of CD200R by microglia was confirmed at the mRNA and protein level using cultured human microglia compared to blood-derived macrophages. Treatment of microglia and macrophages with interleukin-4 and interleukin-13 significantly increased expression of CD200R. Expression of these cytokines was not generally detectable in brain. These data indicate that the anti-inflammatory CD200/CD200R system may be deficient in AD brains. Mechanisms aimed at increasing levels of CD200 and CD200R could have therapeutic potential for controlling inflammation in human neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · cited 1×
“As activated microglia have the potential to produce a wide range of neurotoxic molecules, it was hoped that anti-inflammatory therapies might provide new targets for treating this disease (Launer, 2003;MacKenzie and Munoz, 1998;McGeer, Schulzer, and McGeer, 1996).”
BackgroundDown-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)
Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R., Zurawski, S. M., Blom, B., Homola, M. E., Streit, W. J., Brown, M. H., et al. (2000) · Science · doi:10.1126/science.290.5497.1768 · Cited by 1,022
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740
Combs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721
Reduction of Lipofuscin-like Autofluorescence in Fluorescently Labeled Tissue
Schnell, S. A., Staines, W. A., & Wessendorf, M. W. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700601 · Cited by 688
Inflammatory processes in Alzheimer's disease
McGeer, E. G., & McGeer, P. L. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00124-6 · Cited by 472
The Role of Glial Reaction and Inflammation in Parkinson's Disease
HIRSCH, E. C., BREIDERT, T., ROUSSELET, E., HUNOT, S., HARTMANN, A., & MICHEL, P. P. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07478.x · Cited by 449
Lue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439
Self-citationCharacterization of the CD200 Receptor Family in Mice and Humans and Their Interactions with CD200
Wright, G. J., Cherwinski, H., Foster-Cuevas, M., Brooke, G., Puklavec, M. J., Bigler, M., Song, Y., Jenmalm, M., Gorman, D., McClanahan, T., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3034 · Cited by 434
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms
Sastre, M., Klockgether, T., & Heneka, M. T. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.014 · Cited by 426 · cited 1×
“…presence of activated microglia, reactive astrocytes, and complement activation, particularly in association with amyloid beta (Aβ)-containing plaques, demonstrated that a type of chronic inflammation was ongoing (McGeer and McGeer, 2003;Xiang et al., 2006;Sastre, Klockgether, and Heneka, 2006).”
BackgroundExpression of the histocompatibility glycoprotein HLA-DR in neurological disease
McGeer, P. L., Itagaki, S., & McGeer, E. G. (1988) · Acta Neuropathologica · doi:10.1007/bf00689592 · Cited by 420
CD200 and membrane protein interactions in the control of myeloid cells
Barclay, A. N., Wright, G. J., Brooke, G., & Brown, M. H. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02223-8 · Cited by 416
Wright, G. J., Puklavec, M. J., Willis, A. C., Hoek, R. M., Sedgwick, J. D., Brown, M. H., & Barclay, A. N. (2000) · Immunity · doi:10.1016/s1074-7613(00)00023-6 · Cited by 388
Identification, classification, and expression of RAGE gene splice variants
Hudson, B. I., Carter, A. M., Harja, E., Kalea, A. Z., Arriero, M., Yang, H., Grant, P. J., & Schmidt, A. M. (2008) · The FASEB Journal · doi:10.1096/fj.07-9909com · Cited by 360
mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging
Frank, M. G., Barrientos, R. M., Biedenkapp, J. C., Rudy, J. W., Watkins, L. R., & Maier, S. F. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.013 · Cited by 327 · cited 1×
“One study showed a decrease in CD200 mRNA expression in the hippocampus of rats with increasing age (Frank et al., 2005).”
BackgroundControl of glial immune function by neurons
Neumann, H. (2001) · Glia · doi:10.1002/glia.1108 · Cited by 319
Signaling mechanisms, interaction partners, and target genes of STAT6
HEBENSTREIT, D., WIRNSBERGER, G., HOREJSHOECK, J., & DUSCHL, A. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.01.004 · Cited by 308
Pathogenic role of glial cells in Parkinson's disease
Teismann, P., Tieu, K., Cohen, O., Choi, D., Wu, D. C., Marks, D., Vila, M., Jackson‐Lewis, V., & Przedborski, S. (2003) · Movement Disorders · doi:10.1002/mds.10332 · Cited by 275
Lyons, A., Downer, E. J., Crotty, S., Nolan, Y. M., Mills, K. H. G., & Lynch, M. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1781-07.2007 · Cited by 258 · cited 3×
“As we showed that IL-4 increases CD200R expression by microglia, and others have shown IL-4 to increase neuronal expression of CD200 (Lyons et al., 2007), this common molecular pathway may allow development of agents that can augment both arms of this antiinflammatory system.”
BackgroundResultNonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging
Mackenzie, I. R. A., & Munoz, D. G. (1998) · Neurology · doi:10.1212/wnl.50.4.986 · Cited by 244
Molecular Mechanisms of CD200 Inhibition of Mast Cell Activation
Zhang, S., Cherwinski, H., Sedgwick, J. D., & Phillips, J. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6786 · Cited by 242
Regulation of Myeloid Cell Function through the CD200 Receptor
Jenmalm, M. C., Cherwinski, H., Bowman, E. P., Phillips, J. H., & Sedgwick, J. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.191 · Cited by 226
Elward, K. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00109-3 · Cited by 219
Wright, G. J., Jones, M., Puklavec, M. J., Brown, M. H., & Barclay, A. N. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01163.x · Cited by 217
Role of Interleukin-4 in Regulation of Age-related Inflammatory Changes in the Hippocampus
Nolan, Y., Maher, F. O., Martin, D. S., Clarke, R. M., Brady, M. T., Bolton, A. E., Mills, K. H. G., & Lynch, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412170200 · Cited by 209
Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions
Koning, N., Bö, L., Hoek, R. M., & Huitinga, I. (2007) · Annals of Neurology · doi:10.1002/ana.21220 · Cited by 184
Walker, D. G., Link, J., Lue, L.-F., Dalsing-Hernandez, J. E., & Boyes, B. E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705377 · Cited by 180
Self-citationKretz-Rommel, A., Qin, F., Dakappagari, N., Ravey, E. P., McWhirter, J., Oltean, D., Frederickson, S., Maruyama, T., Wild, M. A., Nolan, M.-J., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5595 · Cited by 178
Mott, R. T., Ait‐Ghezala, G., Town, T., Mori, T., Vendrame, M., Zeng, J., Ehrhart, J., Mullan, M., & Tan, J. (2004) · Glia · doi:10.1002/glia.20009 · Cited by 170
Cheng, C., Tsuneyama, K., Kominami, R., Shinohara, H., Sakurai, S., Yonekura, H., Watanabe, T., Takano, Y., Yamamoto, H., & Yamamoto, Y. (2005) · Modern Pathology · doi:10.1038/modpathol.3800450 · Cited by 164
Giulian, D., Haverkamp, L. J., Yu, J., Karshin, W., Tom, D., Li, J., Kazanskaia, A., Kirkpatrick, J., & Roher, A. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29719 · Cited by 164
Griffiths, M., Neal, J., & Gasque, P. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82002-2 · Cited by 146
Chitnis, T., Imitola, J., Wang, Y., Elyaman, W., Chawla, P., Sharuk, M., Raddassi, K., Bronson, R. T., & Khoury, S. J. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060677 · Cited by 146
Copland, D. A., Calder, C. J., Raveney, B. J. E., Nicholson, L. B., Phillips, J. H., Cherwinski, H. M., Jenmalm, M. C., Sedgwick, J. D., & Dick, A. D. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070272 · Cited by 138
Gan, L., Ye, S., Chu, A., Anton, K., Yi, S.-L., Vincent, V. A. M., von Schack, D., Chin, D. J., Murray, J. C., Lohr, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306183200 · Cited by 136
CD200 is induced by ERK and is a potential therapeutic target in melanoma
Petermann, K. B., Rozenberg, G. I., Zedek, D. C., Groben, P. A., McKinnon, K. P., Buehler, C., Kim, W. Y., Shields, J. M., Penland, S., Bear, J. E., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32163 · Cited by 130
CD200 Is a Ligand for All Members of the CD200R Family of Immunoregulatory Molecules
Gorczynski, R. M., Chen, Z., Yu, K., Lee, L., Wong, S. Y. C., & Marsden, P. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7744 · Cited by 130
The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes
Rijkers, E. S. K., Ruiter, T. E.-D., Baridi, A., Veninga, H., Hoek, R. M., & Meyaard, L. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.07.013 · Cited by 124
Alzheimers Disease-Associated Neurotoxic Mechanisms and Neuroprotective Strategies
Pereira, C., Agostinho, P. M., Moreira, P. I., Cardoso, S. M., & Oliveira, C. R. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007054546117 · Cited by 122
CD200: A putative therapeutic target in cancer
Moreaux, J., Veyrune, J. L., Reme, T. X., Vos, J. D., & Klein, B. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.103 · Cited by 118
Neuroinflammation: a potential therapeutic target
Craft, J. M., Watterson, D. M., & Van Eldik, L. J. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.887 · Cited by 116
Siva, A. C., Xin, H., Qin, F., Oltean, D. I., Bowdish, K. S., & Kretz-Rommel, A. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0429-6 · Cited by 116
Rosenblum, M. D., Olasz, E. B., Yancey, K. B., Woodliff, J. E., Lazarova, Z., Gerber, K. A., & Truitt, R. L. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23461.x · Cited by 116
Xiang, Z., Haroutunian, V., Ho, L., Purohit, D., & Pasinetti, G. M. (2006) · Disease Markers · doi:10.1155/2006/276239 · Cited by 101
CD200 Immunoadhesin Suppresses Collagen-Induced Arthritis in Mice
Gorczynski, R. M., Chen, Z., Yu, K., & Hu, J. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5117 · Cited by 98
PECAM‐1, a key player in neuroinflammation
Kalinowska, A., & Losy, J. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01640.x · Cited by 94
Deckert, M., Sedgwick, J. D., Fischer, E., & Schlüter, D. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0062-z · Cited by 82
Hatherley, D., & Barclay, A. N. (2004) · European Journal of Immunology · doi:10.1002/eji.200425080 · Cited by 77
Launer, L. J. (2003) · Drugs · doi:10.2165/00003495-200363080-00001 · Cited by 75
Postadzhiyan, A., Tzontcheva, A., Kehayov, I. R., & Finkov, B. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.09.001 · Cited by 75
Boudakov, I., Liu, J., Fan, N., Gulay, P., Wong, K. K. W., & Gorczynski, R. (2007) · Transplantation · doi:10.1097/01.tp.0000269795.04592.cc · Cited by 73
Anti-CD200R Ameliorates Collagen-Induced Arthritis in Mice
Gorczynski, R. M., Chen, Z., Lee, L., Yu, K., & Hu, J. (2002) · Clinical Immunology · doi:10.1006/clim.2002.5232 · Cited by 67
Voehringer, D., Rosen, D. B., Lanier, L. L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406997200 · Cited by 65
Nguyen, C. Q., Gao, J.-H., Kim, H., Saban, D. R., Cornelius, J., & Peck, A. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.382 · Cited by 61
Aloy, J. F., Gómez-López, L., Rodríguez-Miguélez, J.-M., Salvia-Roiges, M. D., Jordán-García, I., Ferrer-Codina, I., Carbonell‐Estrany, X., & Jiménez-González, R. (2007) · American Journal of Perinatology · doi:10.1055/s-2007-981851 · Cited by 61
Banerjee, D., & Dick, A. D. (2004) · Ocular Immunology and Inflammation · doi:10.1080/09273940490895326 · Cited by 47
Characterization of human cd200 glycoprotein receptor gene located on chromosome 3q12-13
Vieites, J. M., de la Torre, R., Ortega, M. A., Montero, T. D., Peco, J. M., Sánchez–Pozo, A., Gil, Á., & Suárez, A. (2003) · Gene · doi:10.1016/s0378-1119(03)00562-6 · Cited by 33
Cited by
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975
Para-Inflammation in the Aging Retina
Xu, H., Chen, M., & Forrester, J. V. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.06.001 · Cited by 659
Metadata
- Authors
- Walker, D. G., Dalsing-Hernandez, J. E., Campbell, N. A., & Lue, L.-F.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 215
- Issue
- 1
- Pages
- 5-19
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W1993748281
- Cited by
- 267
- References
- 60
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.